|Videos|November 10, 2022
Challenges Associated With Insomnia Treatments
Author(s)Charlene Gamadelo, MD
Charlene Gamadelo, MD, describes the different categories of FDA approved treatments for insomnia along with challenges associated with these treatments.
Advertisement
Episodes in this series
Advertisement
Related to this article
A new Gallup survey found 51% of women in the United States reported negative healthcare experiences.
Hugh Taylor, MD, explains that imaging in endometriosis is best for ruling out other causes of pelvic pain and cannot exclude the diagnosis.
David Shalowitz, MD, MSHP, emphasizes spreading awareness of opportunistic salpingectomy across specialties while grounding its use in shared decision-making.
SMFM states abortion care is core to MFM practice and urges institutional action to protect high-risk patient access.
Hugh Taylor, MD, welcomes ACOG's new guidance allowing clinical, nonsurgical diagnosis of endometriosis and emphasizes it is a systemic disease affecting the whole body.
FDA accepted for review an sNDA for MIUDELLA copper IUD for a 6-year duration, with a PDUFA date in Q2 2027.
Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.
Amber Watters, MD, MS, explains that emergent delivery after external cephalic version is exceedingly rare and fits within existing protocols, and outlines how to build a version program.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Off-label testosterone dosing, access, and lab monitoring in the US
2
FDA holding public meeting on testosterone use in menopausal women
3
Survey: 51% of US-women report negative healthcare experiences
4
Pellet therapy and practical advice for hesitant prescribers
5